OCU
Joined November 2021
- Tweets 248
- Following 42
- Followers 38
- Likes 3,276
15 Photos and videos
Apr 16
RT @Ocugen: Honored to join the U.S. @CommerceGov Certified Trade Mission to Singapore with TradeMissions.org, connecting with invest…
31
Apr 1
RT @Ocugen: With the successful completion of enrollment in the GARDian3 Phase 2/3 pivotal trial for Stargardt disease, Ocugen expects to f…
31
Rename one of the Navy ships after Chuck Norris. Not the Cesar Chavez one, because it's just a dry cargo ship. The legend needs a destroyer with his name on it. Get it done, @PeteHegseth
366
1,696
13,215
147,823
Mar 19
RT @Ocugen: Imagine your vision slowly fading. For millions, this is reality. Early detection and routine eye exams are key. This #SaveYour…
26
Madpatsy retweeted
Mar 14
🚨 BREAKING: CDC Data Finds the Flu Vaccine ‘Didn’t Really Work’ This Season
“The vaccine had one of the worst effectiveness rates in more than a decade, only working about 25% of the time.”
832
2,670
8,557
1,011,284
Mar 5
RT @Ocugen: Ocugen welcomes Paul Staid as EVP of Operations! With 20 years in biologics & gene therapy operations, he will lead supply cha…
26
Mar 2
RT @Ocugen: Enrollment is now complete for the Phase 3 liMeliGhT trial of #OCU400 for #retinitispigmentosa, the first and largest gene ther…
30
Feb 28
RT @Ocugen: We support @RareDiseaseDay! At Ocugen, we are committed to advancing our novel modifier gene therapies for rare inherited retin…
24
Madpatsy retweeted
Feb 10
Great to have Rita join us at a critical time for growth!
Today, we welcome Rita Johnson-Greene as our new CFO. With over 20 years of healthcare experience, her deep expertise in cell and gene therapy will be vital as we enter a transformative time, beginning with the submission of the 1st of 3 BLAs this year. 🔗bit.ly/4r6PIyk
7
16
102
8,240
Feb 10
RT @Ocugen: CSO Arun Upadhyay shares how gene-agnostic modifier therapies could become a leading paradigm for treating major blindness dise…
17
Madpatsy retweeted
Feb 4
Wonderful news to see Congress pass legislation that reauthorizes the Rare Pediatric Disease Priority Review Voucher (PRV) program included in the Give Kids a Chance Act! #BIOTechCaucus #GiveKidsaChance
1
22
93
7,008
Jan 21
RT @Ocugen: Patients join our clinical trials or EAP with a clear goal: to retain or improve vision. @davidalmeidaMD shares how we support…
19
Starting February 1, FDA will accept applications for the PreCheck Pilot Program, a program to strengthen domestic pharmaceutical manufacturing. Learn more: fda.gov/drugs/drug-safety-an…
6
11
44
11,590
The unique needs of those with celiac and gluten sensitivity have been downplayed and ignored.
The new FDA is changing that. fda.gov/news-events/press-an…
27
48
146
11,718
Madpatsy retweeted
Jan 18
The new FDA is eliminating unnecessary animal testing. @theallinpod
38
67
567
18,677
Madpatsy retweeted
Jan 18
Early-stage research in the U.S. is often mired in red tape, while other countries sprint ahead.
It’s time to move to centralized IRBs and streamline the hospital contracting process.
100
149
936
159,082
.@US_FDA sped up rare disease research via the Rare Pediatric Disease Priority Review Voucher. The Mikaela Naylon Act would get the program going again.
See HHS Assistant Secretary of Legislation Gary Andres' op-ed urging Congress to reauthorize it. ⬇️
realclearhealth.com/articles…
19
26
112
8,389
Madpatsy retweeted
Jan 17
It was an honor to speak at JPM26 this week.
We have an ambitious agenda for this year:
✅ Make more drugs available over-the-counter. No one likes to visit the ER for a nausea medication
✅ Continue to streamline the drug development process
✅ Modernize pathways for revolutionary cell and gene therapies
✅ Use more big data for post-market surveillance
✅ Eliminate the GRAS loophole
50
60
408
28,350